申请人:Janssen Pharmaceutica NV
公开号:US11059828B2
公开(公告)日:2021-07-13
Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
本文描述了二取代的八氢吡咯并[3,4-c]吡咯化合物,它们可用作奥曲肽受体调节剂。此类化合物可用于治疗由奥曲肽活性介导的疾病状态、失调和病症(如失眠)的药物组合物和方法中。